An2 Therapeutics, Inc. (ANTX)

Last Year

17-Apr-23 -- 16-Apr-24

Time Period:
($614.43K) Net Amount
Buy:0--
Sell:($614.43K)$16.00 - $16.15

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell
Insider Trading Sentiment: Buy
Insider Trading Sentiment: Buy
Sentiment Breakdown by Insider
0
(3)
2
(2)
1
(1)
1
0
7
+1
0
+2
0
+3

Two Year Chart

17-Apr-22 -- 16-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
18-Jan-24 6:18 PM
View: 		16-Jan-24
Sale
($312.57K)
Adjuvant Global Health Tech...
10% Owner
Insider Trading Sentiment for Adjuvant Global Health Technology Fund, L.P. at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(9%)
2.6M to 2.37M		0
($307.22K)
(1%)		--$16.00 - $16.15 Show TxnsShow Insider Trades
18-Mar-24 7:27 PM
View: 		15-Mar-24
Grant
0
Chanda Sanjay
Chief Development Officer
Insider Trading Sentiment for Chanda Sanjay at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX3741%
0.73K to 28.23K		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:26 PM
View: 		15-Mar-24
Grant
0
Easom Eric
Chief Executive Officer
Director
Insider Trading Sentiment for Easom Eric at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX9%
1.2M to 1.31M		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:29 PM
View: 		15-Mar-24
Grant
0
Day Lucy
Chief Financial Officer
Insider Trading Sentiment for Day Lucy at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX879%
3.13K to 30.63K		0
0
---- Show TxnsShow Insider Trades
17-Jan-24 5:03 PM
View: 		12-Jan-24
Private Sale (Planned)
($31.23K)
Readnour Robin Shane
Director
Insider Trading Sentiment for Readnour Robin Shane at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(1%)
904.96K to 899.86K		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:27 PM
View: 		15-Mar-24
Grant
0
Eckburg Paul
Chief Medical Officer
Insider Trading Sentiment for Eckburg Paul at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX140%
21.42K to 51.42K		0
0
---- Show TxnsShow Insider Trades
19-Jan-24 7:32 PM
View: 		18-Jan-24
Private Sale
($1.91M)
Zakrzewski Joseph S
Director
Insider Trading Sentiment for Zakrzewski Joseph S at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(17%)
604.08K to 504.08K		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:28 PM
View: 		15-Mar-24
Grant
0
Krause Kevin Michael
Chief Strategy Officer
Insider Trading Sentiment for Krause Kevin Michael at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX1567%
1.91K to 31.91K		0
0
---- Show TxnsShow Insider Trades
22-Aug-23 5:01 PM
View: 		18-Aug-23
Private Purchase
$16.00M
Ra Capital Management, LLC
10% Owner
Insider Trading Sentiment for Ra Capital Management, LLC at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX47%
3.77M to 5.55M		0
0
---- Show TxnsShow Insider Trades
18-Mar-24 7:28 PM
View: 		15-Mar-24
Grant
0
Eizen Joshua M
Chief Legal Officer
Insider Trading Sentiment for Eizen Joshua M at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX1226%
2.45K to 32.45K		0
0
---- Show TxnsShow Insider Trades
18-Jan-24 6:19 PM
View: 		16-Jan-24
Private Sale
($1.96M)
Aziz Kabeer
Director
Insider Trading Sentiment for Aziz Kabeer at An2 Therapeutics, Inc. (ANTX):An2 Therapeutics, Inc. - ANTX(9%)
2.6M to 2.37M		0
($307.22K)
(1%)		--$16.00 - $16.15 Show TxnsShow Insider Trades